Hence, along with traditional tumor markers like AFP and GPC3 (3), it is recommended that colonoscopy should be incorporated into the clinical assessment of HCC patients for the evaluation of the intestinal barrier’s integrity. The gene discussed is AFP; the disease is hepatocellular carcinoma.